TWTim Wilson

Tim Wilson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tim Wilson has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Modelling the impacts of illicit tobacco and e-cigarette market enforcement: Australian case study

    by Samantha Howe, Tim Wilson, Coral E Gartner, Tony Blakely, Driss Ait Ouakrim

    Background In Australia, daily smoking prevalence has fallen below 10% as of 2022–2023. However, prevalence of recent illicit tobacco use has increased, from 1.6% in 2019 to 3.8% in 2025. Recent policy changes have restricted e-cigarette sales to pharmacies, yet illicit supply remains widespread. We aimed to estimate how increasing enforcement against illicit tobacco and e-cigarettes might affect future smoking, vaping and mortality. Methods We used the SHINE-Tobacco simulation model that combines a Markov model of yearly smoking, vaping and dual use transitions, with a proportional multistate lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines (based on 2001–2022/2023 trends), but illicitly traded tobacco and e-cigarettes remain widespread, to four hypothetical enforcement scenarios starting in 2025 that vary by intensity (maximum 90% reduction) and whether increased pharmacy e-cigarette use occurs. Findings Under BAU, daily smoking prevalence declined from 9.1% in 2024 to 6.1% in 2044, while vaping increased from 4.8% to 9.9%. High illicit market enforcement reduced smoking to 4.5% and vaping to 1.3% by 2044. The largest reduction in smoking occurred under high illicit enforcement alongside ongoing e-cigarette use (via pharmacies) for smoking cessation, reducing smoking to 3.0% and averting 8370 deaths over 20 years (95% uncertainty interval 6970–10 100). While the model was moderately sensitive to changes in BAU assumptions, enforcement scenario rankings remained the same across sensitivity analyses. Conclusions Future smoking trajectories in Australia are likely to depend on both illicit product availability and the role of e-cigarettes in cessation. Future research is required to determine how hypothetical enforcement impacts could be achieved.

  • Open Access

    Modelling a tobacco-free generation policy in Australia: population health impacts under illicit market uncertainty

    by Samantha Howe, Tim Wilson, Coral Gartner, Tony Blakely, Driss Ait Ouakrim

    Objective: To estimate the potential health and equity impacts of a tobacco free generation (TFG) and T21 policy (increasing the legal age of sale to 21) in Australia, in the context of a complex market including widespread illicit tobacco and e-cigarette product availability. Design: A Markov macrosimulation model, parameterised with yearly net movements between legal smoking, illicit smoking, vaping, and dual use states, combined with a proportional multi-state lifetable. Setting: The Australian population, modelled as an open cohort for 40-years. Intervention: A ‘business-as-usual’ (BAU) scenario was compared to TFG and T21 policies, with both starting in 2026. Variations to policy impacts were tested under increasing background illicit market enforcement. Main outcome measures: The model estimates the health-adjusted life years (HALYs) and deaths over 40 years, under each scenario, with differences across age and socioeconomic status (SES) presented. Results: The TFG policy reduced daily smoking prevalence among 15-24-year-olds to 5.3% (95% uncertainty interval [UI] 4.8-6.0%) in 20 years’ time, compared to 7% under the T21 policy and 7.6% under BAU trends. Vaping was minimally impacted by either policy. The TFG policy resulted in 75,000 (95% UI 41,900-124,000) HALYs being gained over 40 years. The policy impact was larger when accompanied by increased illicit market enforcement, reducing daily smoking among 15-24-year-olds to 1·3% within 20 years. Both policies had greater prevalence and health impacts on more disadvantaged compared to advantaged SES groups. Conclusion: A TFG policy is expected to produce long-term benefits for the Australian population but would be most effective in combination with increased enforcement of illicit tobacco and e-cigarette markets. Novel strategies to increase quitting in addition to reducing uptake are needed to improve tobacco-related outcomes in the short to medium term. Plain language summary: The known: A ‘tobacco free generation (TFG)’ policy would theoretically minimise youth smoking uptake in Australia but may be undermined by rising illicit tobacco and e-cigarette use. The new: A TFG law in Australia may reduce daily smoking among 15-24-year-olds by 30% within 20 years, though resulting health impacts take longer to manifest. Larger impacts would also occur if smoking uptake via the illicit market was well controlled. The implications: A TFG policy could produce long-term benefits in Australia but should be implemented alongside policies to reduce illicit product supply and improve smoking cessation among adults who already smoke.

  • Open Access

    Modelling the Impacts of Illicit Market Enforcement on Smoking Prevalence: Australian Case Study

    by Samantha Howe, Tim Wilson, Coral Gartner, Tony Blakely, Driss Ait Ouakrim

    Background: In Australia, daily smoking prevalence has fallen to below 10% (as of 2022-23) but 50-60% of the tobacco market is now illicit. Recent policy changes have restricted e-cigarette sales to pharmacy access only, yet illicit supply remains widespread. We aimed to estimate how different levels of enforcement against illicit tobacco and e-cigarette markets might affect future smoking, vaping, and mortality in Australia.Methods: We used the SHINE Tobacco simulation model that combines a Markov model of yearly smoking, vaping, and dual use transitions, with a proportional multi-state lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines, but use of illicitly traded tobacco and e-cigarettes remain widespread. The BAU scenario was compared to four hypothetical enforcement scenarios starting in 2025. Scenarios varied by enforcement intensity (maximum 90% reduction) and whether enforcement reduced all use of illicitly traded e-cigarettes or only naïve vaping, allowing for continued legal access for smoking cessation. Outcomes were daily smoking and vaping prevalence to 2044, and deaths averted over 20 years.Findings: Under BAU, daily smoking prevalence among people aged 15 years and older declined from 9·4% in 2024 to 5·7% in 2044, while vaping increased from 4·8% to 9·8%. High enforcement targeting both illicit tobacco and e-cigarette markets reduced smoking to 4·5% and vaping to 2·4% by 2044. The largest reduction in smoking occurred under high enforcement targeting the illicit tobacco market and naïve vaping only, with continued access to e-cigarettes for cessation, reducing smoking to 3% and averting 4,840 deaths over 20 years (95% uncertainty interval 4,050–5,800). While the model was moderately sensitive to changes in BAU transition rates, the ranking of enforcement scenarios remained the same across sensitivity analyses. Interpretation: Future smoking trajectories in Australia are likely to depend on both availability of products in the illicit market and the role of e-cigarettes in cessation. Stronger enforcement could accelerate smoking declines, but policy choices require balancing reductions in smoking, total nicotine use, and short-term health gains.


  • Open Access

    Future health gain from increasing physical activity in Australia, including multiple physiological effects of physical activity, and falls and injury risk: A simulation study

    by Emily Bourke, Tim Wilson, Ralph Maddison, Tony Blakely

    Background: Previous physical activity simulation studies only account for the effects of cardiovascular diseases, diabetes, dementia, and some cancers, which neglects many of its costs and benefits. We estimate the health and economic impacts of increased physical activity in Australia, including those on mental health, increased injury rate, and conditions mediated by other risk factors, commencing 2021, over 20 years. Methods: We used a Proportional Multistate Lifetable Model specified with disease rate and risk factor forecasts, and causal associations, derived from the Global Burden of Disease study and other sources. Findings: If all Australians shifted to the maximum physical activity level of 4200+ MET-min/week, there would be: 653,000 (230,000 - 1,210,000) or 0.16% more HALYs lived; 9,720 (7,400 to 12,700) or 1.33% fewer deaths before age 75; increased working age income of AUD$16.8 billion ($12.8 -$22.2 billion); and decreased health expenditure of $748 million (-$4.46 billion - $6.98 billion) or 0.02%. Net health gains diminish for each additional 600 MET-min/week increase in physical activity, and above 4,200 MET-min/week the health costs from injuries outweigh the reduction in health costs from avoided disease. Because of injuries, increasing physical activity in the lowest activity group to meet the physical activity guidelines reduces health expenditure more ($1.86 billion; 896 million - 3.13 billion) than shifting to maximum activity levels. Interpretation: Increasing physical activity levels in Australia would improve population health (even allowing for injuries due to participation), reduce health spending, and increase income. Funding: Australian Sports Commission. TB is funded by NHMRC Investigator Grant (2023) #2026992

  • Open Access

    Estimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study

    by Samantha Howe, Tim Wilson, Kylie Morphett, Kate Mason, Germaine Lai, Vaughan W. Rees, Driss Ait Ouakrim


  • Open Access

    Specifying prospective compartmental models of chronic disease

    by Tim Wilson, Samantha Howe, Stephanie Khuu, Abraham Flaxman, Tony Blakely

    Background Determining the impact of preventive interventions on future health and economic outcomes in a given population often requires parameterising disease models with forecast disease incidence, remission and case fatality rates. This paper outlines a method to specify these forecasts, using period estimates over several years from source data that are not necessarily coherent from a cohort perspective. Methods For a given chronic disease, the model is specified by first obtaining and smoothing source data inputs. We used Global Burden of Disease (GBD) period estimates of disease prevalence (p), incidence rates (i) and mortality rates (d) from 1990 to 2019 as a starting point, from which case fatality rates (f) were calculated. Values were smoothed by birth cohort within each calendar year using a quadratic Bezier curve, from which remission rates (r) were inferred. Next, each measure was projected for 20 years using log-linear regression by year, with 10-year age knots, produced independently by sex. Finally, a stochastic optimization algorithm was used to adjust i, f, and r to ensure longitudinal (cohort)-coherence such that they matched simulated forecasts of p and d, which were treated as the reference targets. Model output The method is illustrated by presenting model output for the 20 highest disability-adjusted life year-causing chronic diseases in Australia. Model fit was assessed visually, as well as through the relative and absolute differences between calibration output and targets (p and d). A subset model using GBD input data from 1990-2009 only was also produced and compared to 2019 GBD data to investigate the model's predictive validity. Conclusions Our method is a useful optimization procedure to derive cohort-coherent estimates of chronic disease in simulation models. For this analysis, readily available GBD period rates were used as input data; however, other raw data sources could also be applied for a given disease.


  • Open Access

    Estimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study

    by Samantha Howe, Tim Wilson, Kylie Morphett, Kate Mason, Germaine Lai, Vaughan W. Rees, Driss Ait Ouakrim

    Background: People living in social housing in Australia have higher prevalence of daily smoking and greater exposure to second-hand smoke (SHS), particularly in multi-unit housing where smoke can drift between dwellings. The health impact of this exposure has not been quantified for this population. Methods: We developed a Monte-Carlo matrix model of household SHS exposure, including smoke drift between dwellings in multi-unit housing, and linked it to the SHINE Tobacco simulation platform. The model projected health outcomes for the population living in social housing in the state of Victoria, Australia, over 20 years, comparing scenarios that eradicated SHS exposure and/or smoking with a business-as-usual (BAU) scenario of constant smoking prevalence. Outcomes were health-adjusted life years (HALYs) gained, and premature deaths averted across 31 smoking-attributable and eight SHS-attributable diseases. Findings: Eradicating SHS exposure within the social housing population of Victoria in 2025 could result in 5,350 HALYs (95% uncertainty interval [UI] 4,670-6,120) gained, and 600 premature deaths (95% UI 500-700) averted over 20 years. In multi-unit housing, about half of the SHS-related health gain was attributable to eliminating smoke drift between units. Overall, SHS eradication accounted for approximately 27% of the total health gain achievable if tobacco smoking were fully eradicated in this setting. Interpretation: Reducing SHS exposure in social housing would deliver substantial health benefits, with a large share resulting from preventing smoke drift in multi-unit housing. Better data on population dynamics and smoke infiltration would strengthen estimates and support policy design. Funding: This research was funded by a seed funding grant awarded by the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (NHMRC, GNT1198301)

  • Modelling the potential impacts of limiting vaping product sales to pharmacies

    by Driss Ait Ouakrim, Tim Wilson, Samantha Howe, Jennifer Summers, Richard Edwards, Coral E Gartner, Nick Wilson, Tony Blakely

    Background Vaping rates are increasing globally. Restricting vaping products’ access may result in net population health loss if youths who vape switch to smoking, or net gain if it promotes cessation among people who smoke. We used simulation modelling to assess how two vaping restriction policies—over-the-counter (OTC) pharmacy access or prescription-only access via general practitioners—might impact vaping and smoking rates in Aotearoa New Zealand (A/NZ). Methods We adapted an established Markov model of smoking and vaping, linked to a proportional multistate lifetable, to simulate the A/NZ population from 2023 to 2044. Three business-as-usual (BAU) scenarios (‘low’, ‘medium’ and ‘high’ vaping) were informed by youth vaping trends. Intervention impacts were derived from prior research and expert elicitation. Results Compared with the medium BAU scenario with 50% vaping among 18–24-year olds by 2044, restricting to OTC pharmacy access reduced vaping prevalence by 6% and increased health-adjusted life years (HALYs). Only under the ‘high’ BAU scenario (60% vaping) did interventions marginally increase smoking (2% for OTC). Both interventions averted premature deaths and produced HALY gains. Interpretation Our model suggests modest reductions in vaping prevalence and net health gains from the OTC pharmacy policy, with minor benefits from a prescription-only approach. These findings underscore the importance of balancing the potential smoking cessation benefits of vaping with the need to curb youth uptake. Future research is required to better understand how vaping restriction policies could impact vaping and smoking dynamics in A/NZ, in particular, considering how illicit supply may impact policy effectiveness.

  • Open Access

    Consistent mask use and SARS‐CoV‐2 epidemiology: a simulation modelling study

    by Joshua Szanyi, Samantha Howe, Tim Wilson, Tony Blakely

  • Open Access

    A framework for communicating the utility of models when facing tough decisions in public health

    by Jason Thompson, Roderick McClure, Nick Scott, Margaret Hellard, Romesh Abeysuriya, Rajith Vidinaarachichi, John Thwaites, Jeffrey V Lazarus, Susan Michie, Christopher Roy Bullen, et al.

    The COVID-19 pandemic has brought the discipline of public health, infectious disease, and policy modeling squarely into the spotlight. Never before have decisions regarding public health measures and their impacts been such a topic of international deliberation from the level of individuals and communities through to global leaders. And nor previously have models – developed at rapid pace and often in the absence of complete information - been so central to the decision-making process. However, after more than 18 months of experience with pandemic modeling, policy-makers need to be more confident about which models will be most helpful to support them when taking public health decisions. We combine the authors’ collective international experience of modelling for and with Governments and policy-makers with prior research utilisation scholarship to describe a framework to assist both modelers and policy-makers consider the utility of models that may be available to them when faced with difficult public health and policy decisions. To illustrate these principles, a set of three independent but complementary modeling case-studies undertaken at the same time in NSW, Australia during that state’s unfolding second wave of COVID-19 infections is presented.